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Background: Bupivacaine and levobupivacaine have similar pharmacokinetic and pharmacodynamic characteristics, and
are used regularly in spinal anesthesia. Whether potential differences in their hemodynamic and anesthetic profiles could
determine a differential risk of complications in elderly subjects, is controversial. The main objective was to compare the
effects of intrathecally administered levobupivacaine (LB) versus bupivacaine (B), on regional cerebral O2 saturation during
spinal anesthesia, cognitive status and neurological complications in elderly patients undergoing surgery for hip fracture.
Methods: This was a randomized, controlled, single blind study. 58 patients aged 70 or older undergoing surgery for hip
fracture with spinal anesthesia were allocated with a 1:1 ratio to receive LB or B, combined with fentanyl 15 μg, by
intrathecal route. The primary outcome was the proportion of intraoperative time with regional cerebral desaturation
(≥20% reduction in regional cerebral oxygen saturation from baseline), monitored by near –infrared spectroscopy.
Secondary endpoints included hemodynamic parameters, level of sensory and motor block, changes in Short Portable
Mental Status Questionnaire (SPMSQ), and neurological complications.
Results: The mean percentage of intraoperative time with desaturation in the B group was 6.1% (SD: 17.5) and 4.7%
(SD: 11.9) in the left and right hemisphere respectively; in the LB group the mean was 4.8% (SD: 11.4) in the left
hemisphere and 2.4% (SD: 8.3) in the right one. No statistically significant differences were found between treatment
groups. The level of sensory block at the start of surgery was lower for LB than for B (Th10 vs Th8, p:0.047) and motor
block at 15min was lower for LB (2.5 vs 3, p:0.009). No differences in postoperative SPMSQ were observed. Neurological
complications such as confusional state, agitation or disorientation were reported in 50% of patients in the B group
and 21.4% of patients in the LB group, p = 0.05.
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Conclusions: No statistically significant differences in regional cerebral oxygen saturation or hemodynamic parameters
were observed between both treatment groups. Bupivacaine and levobupivacaine differed in sensory and motor block
achieved. While no differences were observed in cognitive impairment measured by the SPMSQ between treatment
groups neurological complications reported by the physician were more frequent with bupivacaine.
Trial registration: European Union Clinical Trials Register (EudraCT 2013–000846 -20) (April 9th, 2013).
ClinicalTrials.gov (NCT01960543) (September 23rd, 2013).
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Decline in cognitive function in elderly patients during
hospitalization has been, in part, attributed to sudden
changes in the usual environment of the patient, but also,
to the acute morbidity or exacerbation of pre-existing con-
ditions. Geriatric patients suffering a hip fracture who
undergo surgery are an especially frail population, because
of concomitant morbidity, polypharmacy and bleeding. A
multi-factorial intervention aimed to preserve cognitive
function in this population during the acute hospital stay
has shown good results [1]. Spinal anesthesia would be part
of this multi-factorial interventions [1], although the evi-
dence on the differential effects of spinal and general
anesthesia on cognition is controversial. Shorter length of
hospitalization, which could result in fewer complications,
has been described for regional anesthesia, but it does not
reduce mortality [2].
Intraoperative hypotension is an undesirable and frequent
effect of spinal anesthesia, which may complicate a pre-
existing coronary heart disease, worsen previous mental
impairment or precipitate a cerebral stroke. Different strat-
egies to maintain the hemodynamic stability of the patient
include the choice of anesthetic drugs with the most favor-
able hemodynamic profile, and use of reduced doses of
local anesthetic [3]. Racemic bupivacaine (B) and levobupi-
vacaine (LB) are closely related local anesthetic agents;
controversial reports suggest that they have different
anesthetic profiles, with B inducing higher blockade, more
hypotension, and consequently, potentially more cerebral
desaturation [4, 5].
Clinical monitoring of CNS is rarely performed during
spinal anesthesia. Instead, indirect parameters such as arter-
ial pressure, heart rate and arterial O2 saturation are regis-
tered [6]. Regional cerebral oxygen saturation (rCSO2)
through near –infrared spectroscopy, a non invasive moni-
toring that reflects a balance between supply and consump-
tion of O2 to the brain, has been proposed as a tool that
may provide relevant information on CNS ischemic stress,
and may be potentially useful to guide the clinical manage-
ment of the patient during spinal anesthesia [7]. Thus,
rCSO2 might also be useful to assess the CNS conse-
quences of the differences in the hemodynamic andanesthetic profile between two different anesthetic agents
used in spinal anesthesia.
Currently, both B and LB are used interchangeably for
spinal anesthesia in our hospital. Our working hypothesis
was that cerebral desaturation would be higher in patients
treated with B than in those receiving LB, and that this
could be related to worse neurological outcomes. In order
to test the hypothesis, we designed the present pragmatic
randomized clinical trial to compare the effect of B and
LB on regional cerebral oxygen saturation, during spinal
anesthesia in elderly patients undergoing surgery for hip
fracture repair, both administered by spinal route and ac-
cording to routine clinical practice. We also compared the
effects of both anesthetics on postoperative cognitive sta-




This was a randomized, controlled, single-center, single
blind trial conducted at Hospital de Sabadell. The proto-
col was approved by the Ethics Committee of the Centre
on March 2013 (CEIC Corporació Sanitaria Parc Taulí,
Sabadell, reference number 2013/015). The study was
registered at the European Union Clinical Trials Registry
(EudraCT 2013–000846 -20) on April 9th, 2013 and at
ClinicalTrials.gov (NCT01960543) on September 23rd,
2013. All patients received comprehensive information
by the investigator on the study objectives, procedures
and risks and signed the informed consent form before
inclusion. Informed consent in front of a witness was
allowed for patients unable to write or read due to physical
impairment but with preserved cognitive function.
Patients
Patients aged 70 years and older requiring surgery for
hip fracture repair that were suitable to receive spinal
block,were included. Prior to inclusion, patients under-
went cognitive examination by means of the Short Port-
able Mental Status Questionnaire (SPMSQ) [8, 9] and
those with low scores (≥ 8 failures if elementary school,
≥ 7 failures if higher education), were excluded. Patients
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LB (hypersensitivity to amide local anesthetics, severe
aortic stenosis, heart failure or coagulopathies) or if they
refused the regional anesthetic technique.
Methodology
A random list was generated by the clinical pharmacology
unit using Winpepi V2.67 [10]. Sequentially numbered
sealed opaque envelopes were produced containing the
treatment identity for each patient. The list and a copy of
the codes were kept in a file not accessible to the study
team. Inclusion was confirmed by the anesthetist, who
opened the first available sequentially numbered sealed
code to randomize the patient. The study was blind for
patients and for the anesthesiologists who evaluated the
postoperative SPMSQ questionnaire.
Patients were not pre-medicated. Antihypertensive drugs
were discontinued on the day of surgery and restarted at
48 h after surgery. Patients were randomly allocated (ratio
1:1) to receive treatment with racemic bupivacaine (Bupiva-
caine Braun 0.5%®, B. Braun Medical, S. A, Spain) or levo-
bupivacaine (Chirocane®, Abbvie Spain S.L.U, Spain), both
combined with fentanyl 15 μg, by intrathecal route. Both B
and LB were isobaric. Spinal anesthesia was administered
through a 25 gauge spinal needle using the midline or para-
medial approach. The B and LB dose administered was 7
mg if height was < 160 cm and 9mg if height was ≥160 cm,
or when the surgical procedure was a hip prosthesis. Low
doses were used with the objective to maintain the hemo
dynamic stability and minimize intra-operative hypoten-
sion. Supplemental oxygen administration was started after
spinal injection. As per the protocol, if the anesthesia was
not sufficient to initiate surgery, midazolam 1mg and pro-
pofol 30mg could be administered, and if not effective,
general anesthesia was induced and the patient was with-
drawn from the study. In the operating room patients
received 300ml of Lactated Ringer’s over 20min. Electro-
cardiography, cuff for non-invasive blood pressure meas-
urement, and pulse oximetry (Philips Intellivue MP70
Anesthesia) were used for routine monitoring. Hypotension
(systolic blood pressure (SBP) < 100mmHg) was treated
with iv phenylephrine 50–75 μg, and ephedrine 5mg in
case the hypotension did not revert after two doses of
phenylephrine. Bradycardia (heart rate (HR) < 50 beats/
min) was treated with atropine 0.5–1mg.
Outcomes and measurements
Patient characteristics such as ASA physical status, pa-
tient’s pathologies and treatments, type of fracture and
surgery, SPMSQ and preoperative hemoglobin were
recorded. In the operating room, and after spinal anesthe-
sia, the level of sensory block (SB) was evaluated by pin-
prick, and motor block (MB) by the modified Bromage
scale 15min after the spinal injection, before and at theend of the surgery. The modified Bromage scale is used to
measure the intensity of motor block based on the ability
of the patients to move their lower extremities (0 = no par-
alysis, 1 = able to move knees, unable to raise extended
legs, 2 = able to flex ankles unable to flex knees, 3 = unable
to flex ankles, knees or hips). After surgery, SB was evalu-
ated every 30min until regression to L5 level.
Regional cerebral oximetry was measured by near–infra-
red spectroscopy using INVOS 5100 C, 7.00.0014 version
(Somanetics Inc., Troy, MI, 48084 - USA). A first measure
of rSCO2 was performed at entry in the operating room.
A second measurement taken 2min later was considered
as the reference baseline value for each hemisphere, and
values were recorded throughout the study. Regional cere-
bral desaturation was defined as a 20% or larger reduction
in rCSO2 with respect to the ipsilateral baseline value.
Routine monitoring of SBP, mean arterial pressure (MAP),
HR and O2 saturation (O2 Sat) monitoring, volume of
crystalloid infused, intraoperative use of vasoconstrictor
drugs, postoperative hemoglobin and the need for blood
transfusions, were also recorded.
The primary outcome measure was the mean propor-
tion of intra-operative time with regional cerebral oxygen
desaturation, defined as an rSCO2 relative reduction of
20% from baseline value. The area under the curve (AUC)
for the intraoperative time below the desaturation thresh-
old was also calculated (AUC rCSO2 reduced by ≥20%
from baseline). Similar calculations were done using an
absolute value of 50% as a cutoff point (AUC rCSO2 <
50%). Minimum values (trough rCSO2) and time to first
saturation drop under the different cut off points were
also recorded.
Postoperative cognitive impairment was evaluated after
5 to 7 days, by changes in the SPMSQ scores from base-
line. Any adverse events related to nervous system disor-
ders, reported by the responsible physician within 30 days
after surgery were also recorded.
Statistical methods
A sample size of 28 patients per group was calculated
assuming an expected clinically relevant difference between
treatments of 0.15 or higher on the mean proportion of in-
traoperative time with desaturation, with a standard devi-
ation (SD) of 0.2, an alpha of 0.05 and 80% power.
Qualitative variables were described by the number of
valid values and the frequency and percentage of each
category, and compared between groups using Fisher
exact tests. Quantitative variables were described by
measures of central tendency and dispersion, and com-
pared between groups using a Student T test or Mann-
Whitney’s test, as appropriate. A post-hoc bivariate
analysis using the above mentioned statistical tests was
performed to explore the relationship of selected vari-
ables with intraoperative desaturation, postoperative
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Variables showing statistical significance in the bivariate
analysis were included in logistic regression multivari-
ate analyses to explore predictors of regional cerebral
desaturation, cognitive impairment or neurological
complications.
Results
From September 2013 to December 2014, 58 patients
meeting all the eligibility criteria were randomized. In
two patients, the spinal anesthesia was not feasible and
they were converted to general anesthesia; they were ex-
cluded from the analysis. At the start of surgery, three
patients in the LB group needed midazolam + propofol
and one patient in each group received midazolam
alone. Figure 1 displays the disposition of patients, and
Table 1 shows the baseline characteristics of patients.
Most patients (57.1%) had at least 3 comorbidities at
hospital admission. Table 1 shows the most frequent
concomitant diseases per treatment group. 78.3% of pa-
tients were taking 3 or more different medications on a
regular basis, and 53.6% more than 4. Table 1 shows the
treatments most frequently used by patients per treat-
ment group. The majority of patients were operated on
within 2 days after admission, and the time fromFig. 1 Disposition of patientsadmission to surgery was evenly distributed in both
treatment groups.
No significant differences were observed between treat-
ment groups in the proportion of intraoperative time with
desaturation, nor in any of the secondary variables based
on the measurement of rCSO2 (Table 2). Overall, 46% of
patients (13 B; 13 LB) presented a relative reduction in
rCSO2 > 20% from baseline in either one or both hemi-
spheres; considering absolute values of rCSO2 below 50,
64.3% (B) and 53.6% (LB) showed desaturation at some
time point. Hemodynamic parameters (SBP, MAP and
HR) were comparable between the two groups, as well as
the need for vasoconstrictor drugs, although a trend to a
lower SBP for patients was observed in B group (Table 3).
The anesthetic profile for each treatment group is shown
in Table 3. Intraoperative red blood cell transfusion was
required in 3 patients in the B group and in 4 patients in
the LB group. The mean (SD) volume of crystalloid in-
fused were 605.4 (321.6) in the B group and 589.3 (240.5)
mL in the LB group (p = 0.83).
Postoperative SPMSQ scores were overall better than
those observed at baseline (Table 4), and no statistically
significant differences were detected between treatment
groups. Worsening in the SPMSQ score after surgery
was observed in 23.1% of patients in the B group, and in
Table 1 Baseline characteristics
Description of patients Bupivacaine (n = 28) Levobupivacaine (n = 28)
N % N %
Gender
Female 19 67.9 24 85.7
ASA physical status
1 0 0 1 3.6
2 2 7.1 9 32.1
3 26 92.9 18 64.3
Education
Elementary school 26 92.9 27 96.4
High school/University degree 2 7.1 1 3.6
Concomitant diseases
Hypertension 18 64.3 18 64.3
Diabetes Mellitus 13 46.4 6 21.4
Dyslipidemia 7 25.0 8 28.6
Arrhythmia 7 25.0 5 17.9
Renal Failure 7 25.0 3 10.7
Cerebrovascular disease 1 4.2 4 16.7
Depression 1 3.6 6 21.4
Concomitant treatments
Diuretic 14 50.0 11 39.3
ACE inhibitors 10 35.7 7 25.0
AR Blockers 6 21.4 8 28.6
Calcium antagonists 7 25.0 4 14.3
Beta-blockers 5 17.9 6 21.4
CNS drugs 19 67.9 25 89.3
Benzodiazepines 11 39.3 11 39.3
Antidepressants 8 28.6 12 42.9
Fracture type
Pertrochanteric 17 60.7 11 39.3
Subtrochanteric 1 3.6 5 17.9
Femoral neck 8 28.6 7 25
Periprosthetic 1 3.6 2 7.1
Supracondylar 1 3.6 1 3.6
Distal diaphyseal 0 0 2 7.1
Surgery type
Intramedullary internal fixation 16 57.1 14 50.0
Extramedullary internal fixation 5 17.9 8 28.6
Total hip arthroplasty 3 10.7 1 3.6
Cemented arthroplasty 4 14.3 3 10.7
Cementless hemiarthroplasty 0 0 2 7.1
Local anesthetic doses
7 mg 8 28.6 7 25.0
9 mg 20 71.4 21 75.0
Right rCSO2 lower than Left rCSO2 14 50.0 11 39.3
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Table 1 Baseline characteristics (Continued)
Description of patients Bupivacaine (n = 28) Levobupivacaine (n = 28)
N % N %
Mean (SD) n Mean (SD) N
Age (years) 83.1 (5.5) 28 83.7 (6) 28
Weight (Kg) 66 (10.3) 28 67.6 (11.7) 28
Height (cm) 161 (7) 28 159.1 (6.3) 28
Baseline hemoglobin (g/L) 112.6 (19) 28 116.2 (18.1) 28
Duration on surgical intervention (min) 60.6 (24.7) 28 78.9 (35.5) 28
Baseline SBP (mmHg) 150.8 (24.7) 28 148.7 (21.8) 28
Baseline MAP (mmHg) 87.1 (14.2) 27 87.8 (14.4) 27
Baseline HR (bpm) 78.7 (11.7) 28 81.5 (11.5) 28
Baseline oxygen saturation (%) 92.4 (6.6) 28 93.9 (2.7) 28
Baseline rCSO2 (%) Left 59.8 (7.8) 28 59.7 (10.4) 28
Baseline rCSO2 (%) Right 58.8 (9.1) 28 60.1 (11.2) 28
ASA American Society of anesthesiologists, bpm beats per minute, HR heart rate, MBP mean blood pressure, SBP systolic blood pressure, SD standard deviation,
rCSO2 regional cerebral oxygen saturation
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changes from baseline in SPMSQ scores were observed
between treatment groups, even after adjusting by base-
line SPMSQ scores.
Three patients from the B group died, and none in the
LB group (p = 0.24). Reasons were aspiration pneumonia
followed by heart failure, worsening of a pre-existing
chronic renal failure, and sepsis following a respiratory
infection, respectively. None of the deaths were consid-
ered related to the study treatment by the investigators.
Neurological complications were reported more often
in patients in the B group (14, 50%) compared to the LB
group (6, 21.4%), p = 0.0496. Confusional state was re-
ported in 10 patients (7 B, 3 LB), agitation in 3 patients
(2 B, 1 LB), cognitive impairment in 2 patients (1 B, 1
LB) and disorientation in 2 patients (1 B, 1 LB); three
patients experienced agitation and disorientation (1 B),
bradypsychia-dysartria (1 B) and encephalopathy related
to hypercalcemia (1 B).
Baseline mean hemoglobin values were similar in both
treatment groups (112.6 g/L and 116.2 g/L for B and LB
respectively), and the drop in hemoglobin post-surgery
was comparable in both groups (106.2 g/L for B and
110.4 g/L for LB). Anemia was reported as an adverse
event in 80.4% of patients, and was similar for B and LB
groups, with 9 and 6 patients in B and LB groups re-
spectively, requiring postoperative transfusion (p =
0.546). Urinary infections were reported in 4 and 5 pa-
tients, renal failure in 8 and 5 patients, and respiratory
infections and/or respiratory failure in 3 and 3 patients
in B and LB groups, respectively.
The multivariate exploratory analysis showed that in-
traoperative desaturation was associated with low rCSO2
in the right hemisphere at baseline, so that the risk ofdesaturation, increased by 61 fold in patients with base-
line rCSO2 in the lowest quartile, and by 38 fold in those
in the second quartile, as referred to the highest rCSO2
quartile (Table 5 and Fig. 2). Similarly, subjects in the
lower quartile for trough intraoperative MAP had a 29
fold increased risk of desaturation, as compared to the
highest quartile (Table 5 and Fig. 2). No variable was
found to be significantly predictive of postoperative cog-
nitive impairment, defined as a worsening in the SPMSQ
score. In the multivariate analyses, only low SPMSQ
scores at baseline predicted neurological complications
(OR = 1.58 for each additional incorrect answer in the
baseline SPMSQ score, 95%CI: 1.14–2.21).
Discussion
Our study found no significant differences between B
and LB in any of the endpoints based on regional cere-
bral oxygen saturation. Cognitive impairment assess-
ment by SPMSQ did not show mental decline for most
subjects, but patients receiving B had significantly more
reported neurological complications. The population in-
cluded in our study was a very aged population (mean
age of 83.5 years, with 8 (14%) patients aged 90 or older).
Patients receiving LB had lower sensory and motor
blockades, as expected, and those receiving B had a
trend towards lower SBP. This is consistent with the re-
sults reported by Erdil et al. comparing B and LB (7.5
mg) in urologic procedures [5] and can be explained by
a higher density of LB compared with bupivacaine [11].
rCSO2 is determined by a balance between cerebral
oxygen supply and demand, and cerebral oxygen supply
is related to hemoglobin concentration, arterial O2 satur-
ation and blood volume; all of them are factors that can
be adversely affected during spinal anesthesia. Some
Table 2 Intraoperative regional cerebral oxygen saturation with bupivacaine and levobupivacaine
All patients Patients with any desaturation
B LB B LB
Desaturation > 20% below baseline
Left hemisphere (n = 28) (n = 28) (n = 9) (n = 12)
AUC (min %) 14.93 (42.60) 12.43 (30.86) ns 69.67 (72.28) 34.80 (44.63) ns
Time below 20% from baseline (min) 5.57 (14.47) 5.21 (13.14) ns 17.36 (21.84) 12.14 (18.21) ns
% of time with desaturation 6.07 (17.47) 4.82 (11.40) ns 18.9 (27.52) 11.25 (15.49) ns
Time to first deep (min) – – ns 23.67 (22.31) 32.66 (30.27) ns
Right hemisphere (n = 28) (n = 28) ns (n = 9) (n = 10) ns
AUC (min %) 14.32 (35.34) 4.32 (14.98) ns 57.29 (52.43) 15.3 (26.05) ns
Time below 20% from baseline (min) 4.74 (11.87) 2.44 (8.30) ns 14.75 (17.58) 6.84 (13.15) ns
% of time with desaturation 4.01 (9.33) 2.16 (7.08) ns 14.02 (13.24) 6.04 (11.15) ns
Time to first deep (min) – – – 29.28 (25.65) 45.97 (22.56) ns
Desaturation < 50% (absolute values)
Left hemisphere (n = 28) (n = 28) (n = 15) (n = 13)
AUC (min %) 53.07 (108.82) 158.29 (440.69) ns 114.31 (138.06) 340.92 (607.88) ns
Time below 20% from baseline (min) 12.82 (24.37) 16.59 (36.85) ns 23.93 (29.32) 35.75 (48.11) ns
% of time with desaturation 11.62 (19.38) 13.65 (30.69) ns 21.68 (22.24) 29.41 (40.20) ns
Time to first deep (min) – – ns 20.71 (30.77) 30.57 (35.09) ns
Right hemisphere (n = 28) (n = 28) ns (n = 17) (n = 13) ns
AUC (min %) 77.54 (152.84) 134.14 (422.71) ns 127.71 (180.6) 288.9 (594.63) ns
Time below 20% from baseline (min) 15.84 (30.14) 13.32 (31.68) ns 26.09 (35.34) 28.68 (42.20) ns
% of time with desaturation 13.08 (23.03) 11.12 (26.55) ns 21.54 (26,49) 23.94 (35.40) ns
Time to first deep (min) – – – 28.80 (34.42) 19.12 (27.98) ns
Lowest values rCSO2 (%)
(n = 28) (n = 28)
Left hemisphere 49.46 (8.59) 48.32 (11.71) ns
Right hemisphere 48.18 (10.60) 49.86 (11.87) ns
B Bupivacaine, LB Levobupivacaine, AUC area under the curve, rCSO2 regional cerebral oxygen saturation, ns not significant p value. Values expressed as mean
(Standard Deviation) for all patients of the treatment group and for patients who presented desaturation of the measured hemisphere
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shown varying incidences of cerebral desaturation re-
lated to the anesthetic technique [12, 13]. During spinal
anesthesia in urologic surgery, Nishikawa observed a
10% reduction in rCSO2 in patients with higher levels of
sensory block (>Th4.7) [14]. Also, in a randomized study
in elderly patients undergoing abdominal surgery under
general anesthesia, the use of rCSO2 monitoring avoided
cerebral desaturation and was associated with a reduced
incidence of postoperative cognitive decline [6].
We have predefined two cutoff points for assessment
of desaturation: a relative change ≥20% from baseline,
and an absolute saturation below 50%. We compared
the percentage of time that patients spent below these
thresholds, and also the lowest values achieved. These
variables have not previously been reported for very eld-
erly patients with spinal anesthesia, and in our study, we
did not observe any difference between the treatmentgroups, although differences in the anesthetic profile
and rate of complications between B and LB were ob-
served, suggesting that both anesthetic agents are not
equivalent in efficacy.
During surgery, we provided tailored prehydration and
supplementary oxygen, transfused red blood cells and
used vasoconstrictor drugs (mainly phenylephrine) to
manage hypotension in every patient presenting SPB mea-
sures lower than 100mmHg [15]. Despite intensive man-
agement, 46% of patients had at least one drop of rCSO2
of 20% below the baseline value, in at least one cerebral
hemisphere. Reference values of rCSO2 range from 60 to
80% [16]. At baseline our patients had mean rCSO2 values
around 60%, so that drops below 50% were easily and
quickly reached, while reductions of rCSO2 ≥ 20% from
baseline were less frequent. These findings are consistent
with the baseline rCSO2 of 63 ± 8% described by Casati
et al. for relatively healthy patients aged around 70 [5],
Table 3 Anesthetic and intraoperative hemodynamic profile of bupivacaine and levobupivacaine
Anesthetic profile N Bupivacaine N Levobupivacaine
Sensory Block (median – range)
15 min after SI 25 Th9 (Th4-Th12) 20 Th11 (Th5-TL2) p: 0.14
Start of surgery 23 Th8 (Th4-T12) 22 Th10 (Th5 – L2) p: 0.047*
End of surgery 24 Th11 (Th5-L5) 21 Th11 (Th7- L5) p: 0.61
Duration of SB (min) (mean ± SD) 24 178.25 ± 44.89 22 175.18 ± 42.53 p: 0.81
Motor Block (median – range)
15 min after SI 25 3 (2–3) 20 2.5 (1–3) p: 0.009*
Start of surgery 24 3 (2–3) 22 3 (1–3) p: 0.057
End of surgery 25 3 (0–3) 21 1 (0–3) p: 0.21
Duration of MB (min) (mean ± SD) 25 157.04 ± 41.71 23 141.65 ± 56.02 p: 0.29
Time (min) (Mean ± SD)
SI to Start of surgery 25 21.32 ± 6.80 23 19.78 ± 7.45 p: 0.46
SI to End of surgery 25 80.75 ± 27.88 23 97.67 ± 35.97 p: 0.055
Surgery 28 60 ± 24.6 28 78.6 ± 35.4 p: 0.03*
Hemodynamic profile
Patients with hypotension (n/%) 28 19 / 67.8% 28 20 / 71.4% p: 0.99
Minimum values (Mean ± SD)
Lowest SBP (mmHg) 28 84.0 ± 26.43 28 96.03 ± 21.31 p: 0.06
Lowest MAP (mmHg) 28 53.03 ± 14.11 28 56.96 ± 14.20 p: 0.31
Lowest HR (beats/min) 28 65.57 ± 10.66 28 65.57 ± 12.68 p: 0.52
Use of Vasoconstrictor drugs
Phenylephrine n° patients / mean dose (ug) ± SD 28 17 / 258.82 ± 181.12 28 16 / 239.06 ± 153.83 p: 0.73
Ephedrine n° patients / mean dose (mg) ± SD 28 6 / 11.83 ± 5.19 28 7 / 15.57 ± 13.62 p: 0.52
Atropine 0.5 mg (n/%) 28 0/0.0% 28 3/10.7% p:0.24
SB sensory block, MB motor block, SI spinal injection, SBP systolic blood pressure, MAP mean arterial pressure, HR heart rate. SD standard deviation. Motor Block (0
= no paralysis, 1 = able to move knees, unable to raise extended legs, 2 = able to flex ankles unable to flex knees, 3 = unable to flex ankles, knees or hips)
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ginal rCSO2 levels (50–60%), had the greatest changes in
rCSO2 during sleep that may affect subject’s cognition
[17]. Moreover, we observed a wide inter-patient variabil-
ity in the number and duration of drops below our pro-
posed thresholds of rCSO2, especially in subjects already
showing some degree of baseline desaturation. Such vari-
ability may have compromised the power of the study forTable 4 SPMSQ scores at baseline and after 5–7 days
Baseline
B LB
(n = 28) (n = 28)
SPMSQ
0–2 errors 9 (32.1%) 13 (46.4%)
3–4 errors 12 (42.9% 9 (32.1%)
5–7 errors 7 (25.0%) 6 (21.4%)
8 or more errors 0 0
SPMSQ change, mean (SD)
B Bupivacaine, LB Levobupivacaine, SPMSQ Short Portable Mental Status Questionnathe main hypothesis, and may be indicative of either the
lack of suitability of rCSO2 as a surrogate of cerebral oxy-
gen saturation during spinal anesthesia, or of a choice of
thresholds unable to discriminate clinically relevant desat-
uration. Future studies should consider including a more
homogeneous population in terms of rCSO2 and the def-
inition of more stringent thresholds for the main
variables.Post-op
B LB
(n = 26) (n = 28)
ns ns
14 (53.8%) 16 (57.1%)
8 (30.8%) 8 (28.6%)
4 (15.4%) 3 (10.1%)
0 1 (3.7%)
0.50 (1.96) 0.32 (1.63) ns
ire, SD standard deviation, ns not significant p value
Fig. 2 Mean values and dispersion for (A) baseline right hemisphere rCSO2 and (B) minimum intra-operative MAP in patients with and without
intraoperative desaturation. Footer: rCSO2: regional cerebral saturation of oxygen. MAP: Mean arterial pressure
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ation has been found to be significantly associated with
an increased risk of cognitive decline [6, 18], a recent
review did not show evidence of a relationship between
a low rCSO2 and neurological complication [19]. Be-
sides, intrasubject differences in rCSO2 between L and R
during anesthesia has been also been suggested as a risk
factor for neurological impairment [20]. In our study,
the desaturation variables studied did not prove to be
useful as predictors of cognitive decline; however, we
found that neurological complications were more fre-
quent with B. Such observation could be due to chance,
but could also be due to the trends towards lower values
of SBP and MAP in B group than in LB group [21], since
a higher sympathetic block may exaggerate hypotension
after spinal anesthesia. In our study, no standardized
method to assess and report neurological complicationsTable 5 Multivariate model for intraoperative desaturation risk
N Mean
rCSO2 –Righta (overall) 56 59.41
1st quartile 15 47.53
2nd quartile 14 55.79
3rd quartile 12 64.00
4th quartile 15 71.00
MAPminb (overall) 54 55.00
1st quartile 13 36.23
2nd quartile 15 51.80
3rd quartile 13 59.92
4th quartile 13 72.54
Exp
OR Odds Ratio, CI Confidence interval, MAP Mean Arterial Pressure, SD Standard De
aBaseline regional Cerebral Saturation of Oxygen in Right Hemisphere; bMinimum vwas considered, and this variable was only based on the
clinical observation of the physicians. This is a limitation
of the study and may be the reason for this finding.
Our post-hoc multivariate analyses also found signifi-
cant associations between preoperative SPMSQ scores
and NC, and the risk of intraoperative desaturation was
substantial and increasingly higher for patients in the
lower quartiles of baseline rCSO2 in the right hemi-
sphere. Preoperative SPMSQ has been widely reported
in the literature as a risk factor of cognitive decline [1],
but low baseline rCSO2 in the right hemisphere as a risk
factor for desaturation could be further explored as a
potential marker of subjects in whom more preemptive
hemodynamic management could be indicated. Salazar
et al. found that, in patients undergoing total knee re-
placement, right rCSO2 values lower than left rCSO2
was a factor associated with the presence of memorySD OR (CI 95%) p value
10.128 0.020
7.954 61.1 (3.3 to 1127.9) 0.006
1.626 37.6 (2.2 to 635.2) 0.012
2.000 2.1 (0.4 to 12.1) 0.429
2.803 (Ref)
14.17 0.145
7.33 28.7 (1.4 to 604.8) 0.031
2.98 9.9 (0.8 to 122.3) 0.074




alue for Mean Arterial Blood pressure, intraoperative
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and right hemisphere saturation as a factor associated
with cerebral desaturation or cognitive impairment, but
our finding that patients with lower right rCSO2 values
present a higher risk of desaturation may be related to
this asymmetry. This finding should be further explored
in future studies.
Regarding the assessments of cognitive function based
on the SPMSQ, we did not observe differences either,
since few patients worsened their scores after surgery.
SPMSQ is a test easy to administrate and suitable for
very aged patients immobile due to the fracture, who
often have forgotten their glasses and who often had
poor literacy. However, the first assessment was after a
hip fracture and hospital admission, when the patients
were in a estrange environment, in pain and anxious and
were being treated with analgesic and sedating drugs.
Thus, this assessment may not represent the true cogni-
tive status of the patients before hospital admission; in
turn, the second assessment was done after fracture
stabilization, control of pain and beginning of rehabilita-
tion. Resolution of the previous painful conditions may
explain why most patients presented better scores in
comparison to baseline. A population undergoing elect-
ive surgery would be a more appropriate setting to check
the relationship between rCSO2 and cognitive decline.
Finally, 3 (10.3%) subjects died in the B group and none
in LB group. The reported rate of death in this particular
population is 5.3% [2], and the observation is consistent
with these figures, considering the small sample size of
our study that does not have power enough as to detect
statistically significant differences in mortality.
Conclusions
This prospective, randomized, clinical trial in very eld-
erly patients could not show differences in cerebral oxy-
genation between B and LB during spinal anesthesia, but
lower sensory and motor blockade was seen with LB
than with B, and a trend to lower MAP and SPB was ob-
served for B. While no differences were observed in cog-
nitive impairment measured by the SPMSQ between
treatment groups, postoperative neurological complica-
tions as reported by the physician were more frequent in
B. An increased risk for intraoperative cerebral oxygen
desaturation was observed for patients with lower trough
intraoperative MAP and lower baseline rCSO2 values in
the right hemisphere, and neurological complications
were associated to lower cognitive status at the pre-
operative assessment. Finally, rCSO2 was not found as a
predictive factor for cognitive impairment or late neuro-
logical complications.
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